Canakinumab 150 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 150 mg/mL
Reference Brands: Ilaris (USA/EU)
Category: Immune Disorder
Canakinumab is a monoclonal antibody that targets interleukin-1β to reduce inflammation in various autoinflammatory disorders. It is used for conditions such as CAPS, Still’s disease, gout flares, and certain periodic fever syndromes. The drug is administered subcutaneously in controlled doses according to the specific indication.
Canakinumab — third party manufacturing & bulk supply
Canakinumab 150 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Canakinumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Canakinumab →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Canakinumab is used to treat several inflammatory conditions such as Cryopyrin-Associated Periodic Syndromes (CAPS), Familial Mediterranean Fever (FMF), Still’s disease, and certain forms of gouty arthritis. It works by blocking interleukin-1β, a key mediator of inflammation.
Canakinumab is made from a fully human monoclonal antibody specifically designed to neutralize interleukin-1β and reduce inflammation in the body.
The commonly known trade name is Ilaris.
Ilaris is manufactured and marketed by Novartis Pharmaceuticals.
The generic name is canakinumab.
The well-known brand name is Ilaris.
Canakinumab is manufactured in various Novartis facilities located in Switzerland, the USA, and other regulated global manufacturing regions.
Related Products
Etrasimod Arginine
Strength:
2 mg, 4 mg, 6 mg
Form: Tablets
Reference Brands: Velsipity (USA)
View Details
Fostamatinib Disodium
Strength:
100 mg, 150 mg
Form: Tablets
Reference Brands: Tavalisse (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
